Bigmar Clarifies Prior Announcement Regarding Paclitaxel.COLUMBUS, Ohio--(BUSINESS WIRE)--April 18, 2000 Clarifying an April 13, 2000 news bulletin, Bigmar, Inc. (Nasdaq SmallCap:BGMR BGMR Bigmar Inc. (stock symbol) ) reported today that its agreement with Indena S.p.A., a world leader in processing capacity of pharmaceutical extracts, calls for Bigmar to be supplied by Indena with paclitaxel paclitaxel /pac·li·tax·el/ (pak?li-tak´sel) an antineoplastic that promotes and stabilizes polymerization of microtubules, isolated from the Pacific yew tree (Taxus brevifolia); necessary to produce a generic formulation containing the anticancer ingredient. According to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. the agreement, Bigmar will be the exclusive buyer of the paclitaxel necessary to produce the generic formulation, while Indena will continue to supply existing and future clients with paclitaxel. Bigmar is the sole party that will develop the generic drug generic drug, a drug sold or prescribed under the nonproprietary name of its active ingredients or under a generally descriptive name rather than under a brand or trade name. , apply for regulatory approvals and market the generic drug after approval. For seven years, Indena has been producing substantial quantities of paclitaxel and the intermediate agent, DAB-III -- used for its semisynthesis from taxus leaves -- for its clients. Bigmar, Inc.'s strategy is to supply world markets with a line of high-quality, affordably priced pharmaceutical products with a focus on oncology. The company has distribution rights to more than 20 generic oncological products and seven products approved by the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. , which are manufactured in the company's state-of-the-art facilities in Switzerland. Bigmar markets its products through partnerships with pharmaceutical distributors in Europe and the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. and focuses on off-patent oncological drugs. Additional information on Bigmar is available at www.bgmr.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion